Insights into the CD1 lipidome.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 09 07 2024
accepted: 05 08 2024
medline: 6 9 2024
pubmed: 6 9 2024
entrez: 6 9 2024
Statut: epublish

Résumé

CD1 isoforms are MHC class I-like molecules that present lipid-antigens to T cells and have been associated with a variety of immune responses. The lipid repertoire bound and presented by the four CD1 isoforms may be influenced by factors such as the cellular lipidome, subcellular microenvironment, and the properties of the binding pocket. In this study, by shotgun mass spectrometry, we performed a comprehensive lipidomic analysis of soluble CD1 molecules. We identified 1040 lipids, of which 293 were present in all isoforms. Comparative analysis revealed that the isoforms bind almost any cellular lipid.CD1a and CD1c closely mirrored the cellular lipidome, while CD1b and CD1d showed a preference for sphingolipids. Each CD1 isoform was found to have unique lipid species, suggesting some distinct roles in lipid presentation and immune responses. These findings contribute to our understanding of the role of CD1 system in immunity and could have implications for the development of lipid-based therapeutics.

Identifiants

pubmed: 39238636
doi: 10.3389/fimmu.2024.1462209
pmc: PMC11375338
doi:

Substances chimiques

Antigens, CD1 0
Lipids 0
Protein Isoforms 0
Antigens, CD1d 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1462209

Informations de copyright

Copyright © 2024 Szoke-Kovacs, Khakoo, Gogolak and Salio.

Déclaration de conflit d'intérêts

MS, RK and SK were employed Immunocore Ltd. The remaining author declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest. The author MS declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Rita Szoke-Kovacs (R)

Immunocore Ltd, Experimental Immunology, Abingdon, United Kingdom.
Department of Immunology, University of Debrecen, Debrecen, Hungary.

Sophie Khakoo (S)

Immunocore Ltd, Experimental Immunology, Abingdon, United Kingdom.

Peter Gogolak (P)

Department of Immunology, University of Debrecen, Debrecen, Hungary.

Mariolina Salio (M)

Immunocore Ltd, Experimental Immunology, Abingdon, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH